All Disease Treatment & Prevention articles
-
NewsViral infections can accelerate the progression of ALS, researchers find
A new study suggests that common viral infections — like influenza or COVID-19 — may accelerate the onset and progression of amyotrophic lateral sclerosis, or ALS. The findings suggest that it is the immune response triggered by these infections that accelerates the onset and progression of ALS.
-
NewsBlueberries modify gut microbiome in older adults with mild depression
A new pilot study has found that older, sedentary adults who consumed blueberries daily showed a greater, more consistent reduction in depressive symptoms, paired with minor changes in markers of gut microbial enzymes.
-
NewsGut enzyme links microbiota, barrier dysfunction and MASH progression
Metabolic dysfunction-associated steatohepatitis (MASH) is often viewed through the lens of hepatic lipid accumulation, inflammation and fibrosis. A new study identifies intestinal neutral ceramidase as a gut-derived driver of MASH progression through its effects on microbial metabolism, epithelial signalling and intestinal barrier function.
-
News Distinct gut microbiome patterns found in 5 cancer groups and in early-onset cancers
Researchers have discovered distinct gut microbiome patterns in adults 50 or younger with colorectal and breast cancers compared with those diagnosed later in life — one of several findings from an analysis of stool samples from 1,364 patients with cancer across cancer types, stages and treatments.
-
NewsResearchers develop AI tool that reveals hidden clues in the gut microbiome
Researchers are using artificial intelligence to uncover hidden clues among the trillions of bacteria living in the human gut, including changes that could one day help scientists detect diseases earlier.
-
NewsResearchers identify new vaccine target in malaria parasite
Researchers identified a previously uncharacterized site on the parasite’s major surface protein that antibodies can target to block liver infection, potentially preventing the dormant forms responsible for malaria relapses.
-
NewsDrug helps bladder cells to clear urinary infections
Researchers have identified a way to strengthen the bladder cells’ ability to eliminate urinary tract infection bacteria sheltered in the cells of the epiithelium. The drug OM-89, marketed as Uro-Vaxom®, activates cellular degradation pathways in bladder epithelial cells while also increasing the amount of antibiotic that enters them.
-
NewsGut bacteria-derived metabolite contributes to host lifespan extension
Researchers use genetically engineered Escherichia coli to reveal how gut bacteria-derived polyamines extend the lifespan of fruit flies.
-
NewsA shorter, better-tolerated treatment for chagas disease is possible
A 30-day course of benznidazole taken once a day could offer people with chronic Trypanosoma cruzi infection a safer and more practical option than the current standard treatment, taken twice a day for 60 days.
-
NewsTarget identified in treatment of neuroHIV
NeuroHIV occurs when HIV infection affects the function and structural integrity of the brain and, to some extent, the spinal cord and peripheral nervous system. New research has identified a brain protein driving this damage, pointing toward a possible treatment.
-
NewsCould these pills help people with anorexia? A new study aims to find out
A new clinical trial is recruiting people diagnosed with anorexia nervosa as researchers hope to discover if fecal microbiota transplant (FMT) capsules could help better manage this eating disorder.
-
NewsGut microbiome development may help predict type 1 diabetes in children at high risk
A new prospective study found that children at high genetic risk of type 1 diabetes whose gut microbiome development plateaued early had about three times the risk of developing the disease compared with children whose microbiomes continued to mature.
-
NewsBoosted BCG vaccine strategy significantly reduces tuberculosis relapse
A new study reveals that combining an immunotherapy with the traditional Bacille Calmette-Guérin (BCG) vaccine drastically lowers the risk of TB relapse in preclinical models.
-
NewsA tiny bacterium with a huge impact
Researchers have discovered that gut bacteria and the compounds they produce trigger biological processes that the human body on its own can only activate with difficulty. They help suppress inflammation and may also have beneficial effects on fatty liver disease.
-
NewsOral chiral nanozyme protects the heart during chemotherapy by reshaping the gut-heart axis
A chirality-engineered nanozyme restores gut microbiota and host metabolism to prevent doxorubicin-induced cardiotoxicity without compromising anticancer efficacy.
-
NewsStudy supports effectiveness of RSV preventive antibody treatments for infants and provides new way to monitor viral resistance
An analysis of more than 60,000 respiratory syncytial virus (RSV) sequences from around the world found that viral variants associated with resistance to current RSV prevention tools remain rare, according to a study.
-
NewsResearchers discover how Epstein-Barr Virus triggers multiple sclerosis attacks
In a study of blood samples from more than 100 participants with MS, researchers detected increased EBV lytic activity in immune cells up to three months before MS relapse and discovered that these cells also showed elevated expression of genes linked to MS risk.
-
NewsBeyond the gut: Necrotizing enterocolitis drives neurodevelopmental impairment through gut-derived inflammation
A severe gut disease in premature infants, known as necrotizing enterocolitis (NEC), does far more than damage the intestines—it fundamentally alters brain development, leaving up to 40% of survivors with lasting cognitive, motor, and behavioral impairments.
-
NewsCan probiotics help T cells fight solid tumors more effectively?
Transferred T cells often have difficulty reaching tumors and overcoming the strongly immunosuppressive environment surrounding cancer cells. Researchers have combined therapeutic T cells with engineered probiotics, physically attaching the bacteria to the surface of T cells to create a hybrid system called T-FOLactis.
-
NewsGut bacterial enzyme worsens colitis by switching off a protective intestinal signal
Microbiome research often focuses on which microbes are present in the gut and what small molecules they produce. But gut bacteria also make enzymes that can act directly on molecules produced by the host. Researchers report that one such bacterial enzyme can weaken a protective intestinal signal and aggravate colitis in a preclinical model.